LYB vs SMMT · P/E 21, rev $16.37B vs $11.46B cap
LyondellBasell Industries NV (LYB) versus Summit Therapeutics PLC (SMMT) — a side-by-side from cached financials, not a winner call.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Summit Therapeutics PLC (SMMT) is a biotechnology company listed on US.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
SMMT does not have a complete income-statement cache yet.
LYB currently screens at market cap $19.93B and trailing P/E 21.5. SMMT currently screens at market cap $11.46B.
Not investment advice. Open the LYB and SMMT stock pages for the full models.
Not investment advice.